Skip to main content
Top
Published in: Diabetologia 2/2009

01-02-2009 | Article

Metabolic consequences of a 50% partial pancreatectomy in humans

Authors: B. A. Menge, H. Schrader, T. G. K. Breuer, Y. Dabrowski, W. Uhl, W. E. Schmidt, J. J. Meier

Published in: Diabetologia | Issue 2/2009

Login to get access

Abstract

Aims/hypothesis

Partial pancreatectomy is frequently performed in patients with pancreatic tumours or chronic pancreatitis, but little is known about the metabolic impact of this intervention. We examined the effects of approximately 50% partial pancreatectomy on glucose homeostasis and insulin secretion.

Methods

Fourteen patients with chronic pancreatitis, ten patients with pancreatic carcinoma and 13 patients with benign pancreatic tumours or extra-pancreatic masses (control group) underwent 240 min oral glucose tolerance tests before and after pancreatic tail-resection (n = 12), duodenopancreatectomy (n = 19) or duodenum-preserving pancreatic-head resection (n = 6).

Results

Partial pancreatectomy led to a reduction in post-challenge insulin excursions by 49% in chronic pancreatitis patients, 52% in carcinoma patients and 55% in controls (p < 0.05). Nevertheless, post-challenge glucose concentrations were transiently ameliorated after surgery (p < 0.001). In the control participants, pancreatic-head resection caused a transient reduction of post-challenge glycaemia, whereas pancreatic-tail resection increased both fasting and post-challenge glycaemia (p < 0.05). Insulin sensitivity was highest in chronic pancreatitis patients before surgery (p < 0.01), but remained unchanged by the partial pancreatectomy. High pre-operative body weight and elevated fasting glucose levels were associated with poor glycaemic control after surgery.

Conclusions/interpretation

Insulin secretion is diminished after pancreatic-head and -tail resection, but post-challenge glucose concentrations can be ameliorated after pancreatic-head resection. These data highlight the unequal impact of different surgical procedures on glucose control and suggest that obesity and high pre-operative glucose levels should be considered as risk factors for the development of hyperglycaemia after pancreatic surgery.
Literature
1.
go back to reference Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC (2003) Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52:102–110PubMedCrossRef Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC (2003) Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52:102–110PubMedCrossRef
2.
go back to reference Meier JJ, Bhushan A, Butler AE, Rizza RA, Butler PC (2005) Sustained beta-cell apoptosis in patients with long-standing type 1 diabetes: Indirect evidence for islet regeneration. Diabetologia 48:2221–2228PubMedCrossRef Meier JJ, Bhushan A, Butler AE, Rizza RA, Butler PC (2005) Sustained beta-cell apoptosis in patients with long-standing type 1 diabetes: Indirect evidence for islet regeneration. Diabetologia 48:2221–2228PubMedCrossRef
3.
go back to reference Meier JJ (2008) Beta cell mass in diabetes: a realistic therapeutic target. Diabetologia 51:703–713PubMedCrossRef Meier JJ (2008) Beta cell mass in diabetes: a realistic therapeutic target. Diabetologia 51:703–713PubMedCrossRef
4.
go back to reference Leahy JL, Bonner-Weir S, Weir GC (1984) Abnormal glucose regulation of insulin secretion in models of reduced B cell mass. Diabetes 33:667–673PubMedCrossRef Leahy JL, Bonner-Weir S, Weir GC (1984) Abnormal glucose regulation of insulin secretion in models of reduced B cell mass. Diabetes 33:667–673PubMedCrossRef
5.
go back to reference Matveyenko AV, Veldhuis JD, Butler PC (2006) Mechanisms of impaired fasting glucose and glucose intolerance induced by an approximate 50% pancreatectomy. Diabetes 55:2347–2356PubMedCrossRef Matveyenko AV, Veldhuis JD, Butler PC (2006) Mechanisms of impaired fasting glucose and glucose intolerance induced by an approximate 50% pancreatectomy. Diabetes 55:2347–2356PubMedCrossRef
6.
go back to reference Meier JJ, Kjems LL, Veldhuis JD, Lefèbvre P, Butler PC (2006) Post prandial suppression of glucagon secretion depends on intact pulsatile insulin secretion: further evidence for the intraislet insulin hypothesis. Diabetes 55:1051–1056PubMedCrossRef Meier JJ, Kjems LL, Veldhuis JD, Lefèbvre P, Butler PC (2006) Post prandial suppression of glucagon secretion depends on intact pulsatile insulin secretion: further evidence for the intraislet insulin hypothesis. Diabetes 55:1051–1056PubMedCrossRef
7.
go back to reference Ritzel RA, Butler AE, Rizza RA, Veldhuis JD, Butler PC (2006) Relationship between beta-cell mass and fasting blood glucose concentration in humans. Diabetes Care 29:717–718PubMedCrossRef Ritzel RA, Butler AE, Rizza RA, Veldhuis JD, Butler PC (2006) Relationship between beta-cell mass and fasting blood glucose concentration in humans. Diabetes Care 29:717–718PubMedCrossRef
8.
go back to reference Kjems LL, Kirby BM, Welsh EM et al (2001) Decrease in beta-cell mass leads to impaired pulsatile insulin secretion, reduced postprandial hepatic insulin clearance, and relative hyperglucagonemia in the minipig. Diabetes 50:2001–2012PubMedCrossRef Kjems LL, Kirby BM, Welsh EM et al (2001) Decrease in beta-cell mass leads to impaired pulsatile insulin secretion, reduced postprandial hepatic insulin clearance, and relative hyperglucagonemia in the minipig. Diabetes 50:2001–2012PubMedCrossRef
9.
go back to reference Larsen MO, Wilken M, Gotfredsen CF, Carr RD, Svendsen O, Rolin B (2002) Mild streptozotocin diabetes in the Gottingen minipig. A novel model of moderate insulin deficiency and diabetes. Am J Physiol Endocrinol Metab 282:E1342–E1351PubMed Larsen MO, Wilken M, Gotfredsen CF, Carr RD, Svendsen O, Rolin B (2002) Mild streptozotocin diabetes in the Gottingen minipig. A novel model of moderate insulin deficiency and diabetes. Am J Physiol Endocrinol Metab 282:E1342–E1351PubMed
10.
go back to reference Kendall DM, Sutherland DE, Najarian JS, Goetz FC, Robertson RP (1990) Effects of hemipancreatectomy on insulin secretion and glucose tolerance in healthy humans. N Engl J Med 322:898–903PubMedCrossRef Kendall DM, Sutherland DE, Najarian JS, Goetz FC, Robertson RP (1990) Effects of hemipancreatectomy on insulin secretion and glucose tolerance in healthy humans. N Engl J Med 322:898–903PubMedCrossRef
11.
go back to reference Bonner-Weir S, Baxter LA, Schuppin GT, Smith FE (1993) A second pathway for regeneration of adult exocrine and endocrine pancreas. A possible recapitulation of embryonic development. Diabetes 42:1715–1720PubMedCrossRef Bonner-Weir S, Baxter LA, Schuppin GT, Smith FE (1993) A second pathway for regeneration of adult exocrine and endocrine pancreas. A possible recapitulation of embryonic development. Diabetes 42:1715–1720PubMedCrossRef
12.
go back to reference Peshavaria M, Larmie BL, Lausier J et al (2006) Regulation of pancreatic beta-cell regeneration in the normoglycemic 60% partial-pancreatectomy mouse. Diabetes 55:3289–3298PubMedCrossRef Peshavaria M, Larmie BL, Lausier J et al (2006) Regulation of pancreatic beta-cell regeneration in the normoglycemic 60% partial-pancreatectomy mouse. Diabetes 55:3289–3298PubMedCrossRef
13.
go back to reference Menge BA, Tannapfel A, Belyaev O et al (2008) Partial pancreatectomy in adult humans does not provoke beta-cell regeneration. Diabetes 57:142–149PubMedCrossRef Menge BA, Tannapfel A, Belyaev O et al (2008) Partial pancreatectomy in adult humans does not provoke beta-cell regeneration. Diabetes 57:142–149PubMedCrossRef
14.
go back to reference Jimenez RE, Fernandez-Del Castillo C, Rattner DW, Warshaw AL (2003) Pylorus-preserving pancreaticoduodenectomy in the treatment of chronic pancreatitis. World J Surg 27:1211–1216PubMedCrossRef Jimenez RE, Fernandez-Del Castillo C, Rattner DW, Warshaw AL (2003) Pylorus-preserving pancreaticoduodenectomy in the treatment of chronic pancreatitis. World J Surg 27:1211–1216PubMedCrossRef
15.
go back to reference Litwin J, Dobrowolski S, Orlowska-Kunikowska E, Sledzinski Z (2008) Changes in glucose metabolism after Kausch–Whipple pancreatectomy in pancreatic cancer and chronic pancreatitis patients. Pancreas 36:26–30PubMedCrossRef Litwin J, Dobrowolski S, Orlowska-Kunikowska E, Sledzinski Z (2008) Changes in glucose metabolism after Kausch–Whipple pancreatectomy in pancreatic cancer and chronic pancreatitis patients. Pancreas 36:26–30PubMedCrossRef
16.
go back to reference Slezak LA, Andersen DK (2001) Pancreatic resection: effects on glucose metabolism. World J Surg 25:452–460PubMedCrossRef Slezak LA, Andersen DK (2001) Pancreatic resection: effects on glucose metabolism. World J Surg 25:452–460PubMedCrossRef
17.
18.
go back to reference Meier JJ, Nauck MA, Pott A et al (2006) Glucagon-like peptide 2 stimulates glucagon secretion, enhances lipid absorption, and inhibits gastric acid secretion in humans. Gastroenterology. 130:44–54PubMedCrossRef Meier JJ, Nauck MA, Pott A et al (2006) Glucagon-like peptide 2 stimulates glucagon secretion, enhances lipid absorption, and inhibits gastric acid secretion in humans. Gastroenterology. 130:44–54PubMedCrossRef
19.
go back to reference Meier JJ, Hücking K, Holst JJ, Deacon C, Schmiegel W, Nauck MA (2001) Reduced insulinotropic effect of gastric inhibitory polypeptide in first-degree relatives of patients with type 2 diabetes. Diabetes 50:2497–2504PubMedCrossRef Meier JJ, Hücking K, Holst JJ, Deacon C, Schmiegel W, Nauck MA (2001) Reduced insulinotropic effect of gastric inhibitory polypeptide in first-degree relatives of patients with type 2 diabetes. Diabetes 50:2497–2504PubMedCrossRef
20.
go back to reference Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing. Diabetes Care 22:1462–1470PubMedCrossRef Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing. Diabetes Care 22:1462–1470PubMedCrossRef
21.
go back to reference Meier JJ, Gallwitz B, Askenas M et al (2005) Secretion of incretin hormones and the insulinotropic effect of Gastric Inhibitory Polypeptide (GIP) in women with a history of gestational diabetes. Diabetologia 48:1872–1881PubMedCrossRef Meier JJ, Gallwitz B, Askenas M et al (2005) Secretion of incretin hormones and the insulinotropic effect of Gastric Inhibitory Polypeptide (GIP) in women with a history of gestational diabetes. Diabetologia 48:1872–1881PubMedCrossRef
22.
go back to reference Permert J, Adrian TE, Jacobsson P, Jorfelt L, Fruin AB, Larsson J (1993) Is profound peripheral insulin resistance in patients with pancreatic cancer caused by a tumor-associated factor. Am J Surg 165:61–66 discussion 66–7PubMedCrossRef Permert J, Adrian TE, Jacobsson P, Jorfelt L, Fruin AB, Larsson J (1993) Is profound peripheral insulin resistance in patients with pancreatic cancer caused by a tumor-associated factor. Am J Surg 165:61–66 discussion 66–7PubMedCrossRef
23.
go back to reference Dugan MC, Sarkar FH (1998) Current concepts in pancreatic cancer: symposium summary. Pancreas 17:325–333PubMedCrossRef Dugan MC, Sarkar FH (1998) Current concepts in pancreatic cancer: symposium summary. Pancreas 17:325–333PubMedCrossRef
24.
go back to reference Permert J, Ihse I, Jorfeldt L, von Schenck H, Arnqvist HJ, Larsson J (1993) Pancreatic cancer is associated with impaired glucose metabolism. Eur J Surg 159:101–107PubMed Permert J, Ihse I, Jorfeldt L, von Schenck H, Arnqvist HJ, Larsson J (1993) Pancreatic cancer is associated with impaired glucose metabolism. Eur J Surg 159:101–107PubMed
25.
go back to reference Horowitz M, Edelbroek MA, Wishart JM, Straathof JW (1993) Relationship between oral glucose tolerance and gastric emptying in normal healthy subjects. Diabetologia 36:857–862PubMedCrossRef Horowitz M, Edelbroek MA, Wishart JM, Straathof JW (1993) Relationship between oral glucose tolerance and gastric emptying in normal healthy subjects. Diabetologia 36:857–862PubMedCrossRef
26.
go back to reference Horowitz M, O’Donovan D, Jones KL, Feinle C, Rayner CK, Samsom M (2002) Gastric emptying in diabetes: clinical significance and treatment. Diabetic Med 19:177–194PubMedCrossRef Horowitz M, O’Donovan D, Jones KL, Feinle C, Rayner CK, Samsom M (2002) Gastric emptying in diabetes: clinical significance and treatment. Diabetic Med 19:177–194PubMedCrossRef
27.
go back to reference Meier JJ, Gallwitz B, Salmen S et al (2003) Normalization of glucose concentrations and deceleration of gastric emptying after solid meals during intravenous glucagon-like peptide 1 in patients with type 2 diabetes. J Clin Endocrinol Metab 88:2719–2725PubMedCrossRef Meier JJ, Gallwitz B, Salmen S et al (2003) Normalization of glucose concentrations and deceleration of gastric emptying after solid meals during intravenous glucagon-like peptide 1 in patients with type 2 diabetes. J Clin Endocrinol Metab 88:2719–2725PubMedCrossRef
29.
go back to reference Fernandez-del Castillo C, Rattner DW, Warshaw AL (1995) Standards for pancreatic resection in the 1990s. Arch Surg 130:295–299 discussion 299–300PubMed Fernandez-del Castillo C, Rattner DW, Warshaw AL (1995) Standards for pancreatic resection in the 1990s. Arch Surg 130:295–299 discussion 299–300PubMed
30.
go back to reference Jimenez RE, Fernandez-del Castillo C, Rattner DW, Chang Y, Warshaw AL (2000) Outcome of pancreaticoduodenectomy with pylorus preservation or with antrectomy in the treatment of chronic pancreatitis. Ann Surg 231:293–300PubMedCrossRef Jimenez RE, Fernandez-del Castillo C, Rattner DW, Chang Y, Warshaw AL (2000) Outcome of pancreaticoduodenectomy with pylorus preservation or with antrectomy in the treatment of chronic pancreatitis. Ann Surg 231:293–300PubMedCrossRef
31.
go back to reference Kobayashi I, Miyachi M, Kanai M et al (1998) Different gastric emptying of solid and liquid meals after pylorus-preserving pancreatoduodenectomy. Br J Surg 85:927–930PubMedCrossRef Kobayashi I, Miyachi M, Kanai M et al (1998) Different gastric emptying of solid and liquid meals after pylorus-preserving pancreatoduodenectomy. Br J Surg 85:927–930PubMedCrossRef
32.
go back to reference Strommer L, Raty S, Hennig R et al (2005) Delayed gastric emptying and intestinal hormones following pancreatoduodenectomy. Pancreatology 5:537–544PubMedCrossRef Strommer L, Raty S, Hennig R et al (2005) Delayed gastric emptying and intestinal hormones following pancreatoduodenectomy. Pancreatology 5:537–544PubMedCrossRef
33.
go back to reference Sato T, Imamura M, Matsuro S, Sasaki I, Ohneda A (1986) Gastric acid secretion and gut hormone release in patients undergoing pancreaticoduodenectomy. Surgery 99:728–734PubMed Sato T, Imamura M, Matsuro S, Sasaki I, Ohneda A (1986) Gastric acid secretion and gut hormone release in patients undergoing pancreaticoduodenectomy. Surgery 99:728–734PubMed
34.
go back to reference Nyboe Andersen B, Krarup T, Thorsgaard Pedersen NT, Faber OK, Hagen C, Worning H (1982) B cell function in patients with chronic pancreatitis and its relation to exocrine pancreatic function. Diabetologia 23:86–89PubMedCrossRef Nyboe Andersen B, Krarup T, Thorsgaard Pedersen NT, Faber OK, Hagen C, Worning H (1982) B cell function in patients with chronic pancreatitis and its relation to exocrine pancreatic function. Diabetologia 23:86–89PubMedCrossRef
35.
go back to reference Larsen S, Hilsted J, Tronier B, Worning H (1987) Metabolic control and B cell function in patients with insulin-dependent diabetes mellitus secondary to chronic pancreatitis. Metabolism 36:964–967PubMedCrossRef Larsen S, Hilsted J, Tronier B, Worning H (1987) Metabolic control and B cell function in patients with insulin-dependent diabetes mellitus secondary to chronic pancreatitis. Metabolism 36:964–967PubMedCrossRef
36.
go back to reference Permert J, Ihse I, Jorfeldt L, von Schenck H, Arnquist HJ, Larsson J (1993) Improved glucose metabolism after subtotal pancreatectomy for pancreatic cancer. Br J Surg 80:1047–1050PubMedCrossRef Permert J, Ihse I, Jorfeldt L, von Schenck H, Arnquist HJ, Larsson J (1993) Improved glucose metabolism after subtotal pancreatectomy for pancreatic cancer. Br J Surg 80:1047–1050PubMedCrossRef
37.
go back to reference Donev S, Petkov P, Marquie G, Duhault J, Jablenska R (1989) Immunohistochemical investigations of the endocrine pancreas in normoglycemic sand rats (Psammomys obesus). Acta Diabetol Lat 26:309–313PubMedCrossRef Donev S, Petkov P, Marquie G, Duhault J, Jablenska R (1989) Immunohistochemical investigations of the endocrine pancreas in normoglycemic sand rats (Psammomys obesus). Acta Diabetol Lat 26:309–313PubMedCrossRef
38.
go back to reference Baetens D, Malaisse-Lagae F, Perrelet A, Orci L (1979) Endocrine pancreas: three-dimensional reconstruction shows two types of islets of Langerhans. Science 206:1323–1325PubMedCrossRef Baetens D, Malaisse-Lagae F, Perrelet A, Orci L (1979) Endocrine pancreas: three-dimensional reconstruction shows two types of islets of Langerhans. Science 206:1323–1325PubMedCrossRef
39.
go back to reference Yoon KH, Ko SH, Cho JH et al (2003) Selective beta-cell loss and alpha-cell expansion in patients with type 2 diabetes mellitus in Korea. J Clin Endocrinol Metab 88:2300–2308PubMedCrossRef Yoon KH, Ko SH, Cho JH et al (2003) Selective beta-cell loss and alpha-cell expansion in patients with type 2 diabetes mellitus in Korea. J Clin Endocrinol Metab 88:2300–2308PubMedCrossRef
40.
go back to reference Robertson RP, Lanz KJ, Sutherland DE, Seaquist ER (2002) Relationship between diabetes and obesity 9 to 18 years after hemipancreatectomy and transplantation in donors and recipients. Transplantation 73:736–741PubMedCrossRef Robertson RP, Lanz KJ, Sutherland DE, Seaquist ER (2002) Relationship between diabetes and obesity 9 to 18 years after hemipancreatectomy and transplantation in donors and recipients. Transplantation 73:736–741PubMedCrossRef
41.
go back to reference Kumar AF, Gruessner RW, Seaquist ER (2008) Risk of glucose intolerance and diabetes in hemipancreatectomized donors selected for normal preoperative glucose metabolism. Diabetes Care 9:9 Kumar AF, Gruessner RW, Seaquist ER (2008) Risk of glucose intolerance and diabetes in hemipancreatectomized donors selected for normal preoperative glucose metabolism. Diabetes Care 9:9
42.
go back to reference Jalleh RP, Williamson RC (1992) Pancreatic exocrine and endocrine function after operations for chronic pancreatitis. Ann Surg 216:656–662PubMedCrossRef Jalleh RP, Williamson RC (1992) Pancreatic exocrine and endocrine function after operations for chronic pancreatitis. Ann Surg 216:656–662PubMedCrossRef
43.
go back to reference Miyata M, Takao T, Uozumi T, Okamoto E, Manabe H (1974) Insulin secretion after pancreatoduodenectomy. Ann Surg 179:494–498PubMedCrossRef Miyata M, Takao T, Uozumi T, Okamoto E, Manabe H (1974) Insulin secretion after pancreatoduodenectomy. Ann Surg 179:494–498PubMedCrossRef
44.
go back to reference Beger HG, Krautzberger W, Bittner R, Buchler M, Limmer J (1985) Duodenum-preserving resection of the head of the pancreas in patients with severe chronic pancreatitis. Surgery 97:467–473PubMed Beger HG, Krautzberger W, Bittner R, Buchler M, Limmer J (1985) Duodenum-preserving resection of the head of the pancreas in patients with severe chronic pancreatitis. Surgery 97:467–473PubMed
Metadata
Title
Metabolic consequences of a 50% partial pancreatectomy in humans
Authors
B. A. Menge
H. Schrader
T. G. K. Breuer
Y. Dabrowski
W. Uhl
W. E. Schmidt
J. J. Meier
Publication date
01-02-2009
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 2/2009
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-008-1219-1

Other articles of this Issue 2/2009

Diabetologia 2/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.